Filing Details

Accession Number:
0001326110-23-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-05 21:52:51
Reporting Period:
2023-06-05
Accepted Time:
2023-06-05 21:52:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326110 Immunitybio Inc. IBRX Biological Products, (No Disgnostic Substances) (2836) 431979754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1371407 D Michael Blaszyk C/O Immunitybio, Inc.
3530 John Hopkins Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-05 23,430 $2.72 23,430 No 4 P Indirect By trust
Common Stock Acquisiton 2023-06-05 48,000 $2.77 71,430 No 4 P Indirect By trust
Common Stock Acquisiton 2023-06-05 485 $2.75 71,915 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 193,667 Direct